Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 104,500 |
5 mg | 在庫あり | ¥ 219,500 |
10 mg | 在庫あり | ¥ 296,000 |
25 mg | 在庫あり | ¥ 441,000 |
50 mg | 在庫あり | ¥ 594,500 |
100 mg | 在庫あり | ¥ 799,000 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 213,000 |
説明 | Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others. |
分子量 | 299.35 |
分子式 | C15H13N3O2S |
CAS No. | 1007581-62-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11 mg/mL (36.75 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cancer-Targeting Compound 1 1007581-62-5 Others Cancer Targeting Compound 1 CancerTargeting Compound 1 Inhibitor inhibitor inhibit